00000000|MMI|128.30|Togo|C0040363|[geoa]|["TO"-tx-23-"to"-adv-0,"TO"-tx-22-"to"-adv-0,"TO"-tx-21-"To"-adv-0,"TO"-tx-18-"to"-adv-0,"TO"-tx-17-"to"-adv-0,"TO"-tx-9-"to"-adv-0]|TX|4259/2;[4081/2],[4116/2];4036/2;3643/2;3516/2;1875/2|Z01.058.290.190.800
00000000|MMI|128.30|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-23-"to"-adv-0,"TO"-tx-22-"to"-adv-0,"TO"-tx-21-"To"-adv-0,"TO"-tx-18-"to"-adv-0,"TO"-tx-17-"to"-adv-0,"TO"-tx-9-"to"-adv-0]|TX|4259/2;[4081/2],[4116/2];4036/2;3643/2;3516/2;1875/2|D08.811.520.224.800
00000000|MMI|125.41|Angioedemas, Hereditary|C0019243|[dsyn]|["Hereditary angio oedema"-tx-18-"Hereditary Angioedema"-noun-0,"Hereditary angio oedema"-tx-9-"HEREDITARY ANGIOEDEMA"-noun-0,"Hereditary angio oedema"-tx-9-"Hereditary Angioedema"-noun-0,"Hereditary angio oedema"-tx-9-"Hereditary angioedema"-noun-0,"Hereditary angio oedema"-tx-1-"Hereditary angioedema"-noun-0]|TX|3653/21;2400/21;2181/21;[2295/21],[2847/21];66/21|C14.907.079.500;C16.320.078;C17.800.862.945.066.500;C20.543.480.904.066.500
00000000|MMI|125.37|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-25-"DISCHARGE"-noun-0,"Discharge"-tx-21-"DISCHARGE"-noun-0,"Discharge"-tx-9-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Patient Discharge"-tx-2-"DISCHARGE PATIENT"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4388/9;3996/9;2226/9;470/9;256/17;174/9|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|88.18|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-9-"ASA"-noun-0,"ASA"-tx-3-"ASA"-noun-0,"ASPIRIN"-tx-3-"ASPIRIN"-noun-0]|TX|2441/3;493/3;514/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|68.28|Mongolia|C0026410|[geoa]|["MG"-tx-6-"MG"-noun-0,"MG"-tx-4-"mg"-noun-0,"MG"-tx-3-"MG"-noun-0]|TX|1477/2;[813/2],[871/2],[893/2];542/2|Z01.252.474.651
00000000|MMI|68.17|Digoxin|C0012265|[orch,phsu]|["DIGOXIN"-tx-6-"DIGOXIN"-noun-0]|TX|[1138/7],[1312/7],[1402/7]|D04.808.155.580.130.500.436;D04.808.155.580.130.688;D09.408.180.261.436
00000000|MMI|66.81|Dominican Republic|C0013014|[geoa]|["DR"-tx-22-"Dr"-noun-0,"DR"-tx-21-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4212/2;4054/2;1772/2;1686/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|63.08|Portugal|C0032729|[geoa]|["PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[1223/2],[1320/2],[1480/2];938/2;725/2;545/2|Z01.542.727
00000000|MMI|58.72|District of Columbia|C0012764|[geoa]|["D.C."-tx-22-"d/c"-noun-0,"D.C."-tx-18-"d/c"-noun-0,"D.C."-tx-2-"D/C"-noun-0]|TX|4179/3;3714/3;333/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|53.81|Physicians|C0031831|[prog]|["DR"-tx-22-"Dr"-noun-0,"DR"-tx-21-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4212/2;4054/2;1772/2;1686/2|M01.526.485.810;N02.360.810
00000000|MMI|49.50|Levothyroxine Sodium|C0079691|[aapp,horm,phsu]|["Laevothyroxine sodium"-tx-6-"LEVOTHYROXINE SODIUM"-noun-0]|TX|[1111/20],[1193/20],[1375/20]|D06.472.931.812;D12.125.072.050.767
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-9-"DIAGNOSIS"-noun-0]|TX|[2170/9],[2323/9]|x.x.x.x.x.x.x
00000000|MMI|45.34|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-9-"ASA"-noun-0,"ASA"-tx-3-"ASA"-noun-0]|TX|2441/3;493/3|D08.811.277.352.827.070.250
00000000|MMI|45.09|Coding|C0009219|[ocac]|["code"-tx-3-"CODE"-noun-0,"code"-tx-3-"code"-noun-0]|TX|417/4;435/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|43.95|Override|C1547671|[acty]|["Override"-tx-6-"Override"-verb-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"overridden"-noun-0,"Override"-tx-4-"override"-verb-0,"Override"-tx-3-"Override"-verb-0,"Override"-tx-3-"overridden"-noun-0]|TX|[1229/8],[1246/8];[1157/8],[1421/8];1025/8;1013/10;688/8;569/8;557/10|
00000000|MMI|42.15|Vision|C0042789|[orgf]|["see"-tx-22-"see"-verb-0,"see"-tx-18-"see"-verb-0]|TX|4175/3;3710/3|F02.830.816.964;G02.111.087.800.480.900;G02.149.115.800.480.900;G04.299.880.480.900;G11.561.600.810.964;G14.640.816
00000000|MMI|41.37|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-22-"allergy"-noun-0,"Allergy"-tx-18-"ALLERGY"-noun-0,"Allergy"-tx-9-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|4064/7;3578/7;1910/7;631/7|H02.403.044
00000000|MMI|40.55|Appointments|C0003629|[idcn]|["Appointment"-tx-23-"appointment"-noun-0,"Appointment"-tx-22-"appointment"-noun-0,"Appointment"-tx-9-"appointment"-noun-0,"Appointment"-tx-7-"APPOINTMENT"-noun-0]|TX|4281/11;4096/11;1819/11;1668/11|N04.452.095
00000000|MMI|39.50|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-22-"d/c"-noun-0,"D & C"-tx-18-"d/c"-noun-0,"D & C"-tx-2-"D/C"-noun-0]|TX|4179/3;3714/3;333/3|E04.157.310;E04.950.300.299
00000000|MMI|36.40|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-22-"allergy"-noun-0,"ALLERGY"-tx-18-"ALLERGY"-noun-0,"ALLERGY"-tx-9-"ALLERGY"-noun-0,"ALLERGY"-tx-4-"ALLERGY"-noun-0,"Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|4064/7;3578/7;1910/7;631/7;644/11|C20.543
00000000|MMI|32.44|Deep Vein Thrombosis|C0149871|[dsyn]|["DVT NOS"-tx-9-"DVT"-noun-0]|TX|[2529/3],[2574/3]|C14.907.355.830.925
00000000|MMI|32.37|Danazol|C0010961|[horm,orch,phsu]|["DANAZOL"-tx-18-"Danazol"-noun-0,"DANAZOL"-tx-4-"DANAZOL"-noun-0]|TX|3691/7;731/7|D04.808.745.432.235
00000000|MMI|30.42|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-6-"grapefruit"-noun-0]|TX|1527/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|30.09|To|C1883351|[qlco]|["To"-tx-23-"to"-adv-0,"To"-tx-22-"to"-adv-0,"To"-tx-21-"To"-adv-0,"To"-tx-18-"to"-adv-0,"To"-tx-17-"to"-adv-0,"To"-tx-9-"to"-adv-0]|TX|4259/2;[4081/2],[4116/2];4036/2;3643/2;3516/2;1875/2|
00000000|MMI|29.46|Dyspnea|C0013404|[sosy]|["SHORTNESS OF BREATH"-tx-20-"shortness of breath"-noun-1,"SOB"-tx-11-"sob"-noun-1]|TX|3921/19;3047/3|C08.618.326;C23.888.852.371
00000000|MMI|29.46|Quinidine|C0034414|[orch,phsu]|["QUINIDINE"-tx-9-"Quinidine"-noun-0]|TX|[1960/9],[2022/9]|D03.132.206.636;D03.438.810.699;D03.605.687.637
00000000|MMI|29.46|Quinidine Sulfate|C0034415|[orch,phsu]|["Quinidine sulphate"-tx-9-"quinidine sulfate"-noun-0]|TX|[1972/17],[2034/17]|D03.132.206.636;D03.438.810.699;D03.605.687.637
00000000|MMI|28.91|Novocain|C1608242|[orch,phsu]|["Novocain"-tx-9-"Novocain"-noun-0]|TX|2100/8|D02.241.223.100.050.500.906;D02.455.426.559.389.127.020.937.906
00000000|MMI|28.91|Novocaine|C0028460|[orch,phsu]|["novocain"-tx-9-"Novocain"-noun-0]|TX|2100/8|D02.241.223.100.050.500.906;D02.455.426.559.389.127.020.937.906
00000000|MMI|28.37|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-22-"allergy"-noun-0,"Allergy"-tx-18-"ALLERGY"-noun-0,"Allergy"-tx-9-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|4064/7;3578/7;1910/7;631/7|C20.543
00000000|MMI|27.26|Triticum|C0087114|[plnt]|["Wheat"-tx-7-"wheat"-noun-0]|TX|1579/5|B01.650.940.800.575.100.822.918
00000000|MMI|27.26|Triticum aestivum|C1123020|[plnt]|["Wheat"-tx-7-"wheat"-noun-0]|TX|1579/5|B01.650.940.800.575.100.822.918
00000000|MMI|27.22|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-24-"M.D"-noun-0,"M.D."-tx-6-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-3-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|4346/3;1294/3;1073/3;617/3;412/3|
00000000|MMI|26.30|Atrial Fibrillation|C0004238|[dsyn]|["AFib"-tx-14-"afib"-noun-0,"AFib"-tx-9-"AFIB"-noun-0]|TX|3199/4;2422/4|C14.280.067.198;C23.550.073.198
00000000|MMI|26.03|Liver Function Tests|C0023901|[lbpr]|["LFT"-tx-23-"LFT's"-noun-0,"LFT"-tx-14-"LFT"-noun-0]|TX|4249/5;3247/3|E01.370.372.460
00000000|MMI|24.11|Levofloxacin|C0282386|[antb,orch]|["LEVOFLOXACIN"-tx-9-"Levofloxacin"-noun-0]|TX|1994/12|D03.438.810.835.322.500.500
00000000|MMI|24.11|Penicillins|C0030842|[antb,orch]|["PENICILLINS"-tx-9-"Penicillins"-noun-0]|TX|1946/11|D02.065.589.099.750;D02.886.108.750;D03.438.260.825;D03.605.084.737;D04.075.080.875.099.221.750
00000000|MMI|23.48|SERPING1 gene|C1412922|[gngm]|["angioedema, hereditary"-tx-18-"Hereditary Angioedema"-noun-0,"angioedema, hereditary"-tx-9-"HEREDITARY ANGIOEDEMA"-noun-0,"angioedema, hereditary"-tx-9-"Hereditary Angioedema"-noun-0,"angioedema, hereditary"-tx-9-"Hereditary angioedema"-noun-0,"angioedema, hereditary"-tx-1-"Hereditary angioedema"-noun-0]|TX|3653/21;2400/21;2181/21;[2295/21],[2847/21];66/21|
00000000|MMI|23.42|Daily|C0332173|[tmco]|["/d"-tx-17-"d"-noun-0,"QD"-tx-6-"QD"-noun-0,"/day"-tx-4-"day"-noun-0,"QD"-tx-4-"QD"-noun-0,"QD"-tx-3-"QD"-noun-0]|TX|3496/1;1226/2;[881/3],[904/3];728/2;548/2|
00000000|MMI|22.71|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-23-"follow up"-adj-0,"FOLLOW-UP"-tx-22-"Follow up"-adj-0,"FOLLOW-UP"-tx-21-"follow up"-adj-0,"FOLLOW-UP"-tx-9-"follow up"-adj-0,"FOLLOW-UP"-tx-8-"follow up"-adj-0,"FOLLOW-UP"-tx-7-"FOLLOW UP"-adj-0]|TX|4271/9;4193/9;4039/9;1809/9;1713/9;1658/9|
00000000|MMI|22.71|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-23-"follow up"-adj-0,"Follow-Up"-tx-22-"Follow up"-adj-0,"Follow-Up"-tx-21-"follow up"-adj-0,"Follow-Up"-tx-9-"follow up"-adj-0,"Follow-Up"-tx-8-"follow up"-adj-0,"Follow-Up"-tx-7-"FOLLOW UP"-adj-0]|TX|4271/9;4193/9;4039/9;1809/9;1713/9;1658/9|
00000000|MMI|22.71|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-23-"follow up"-adj-0,"Follow-up"-tx-22-"Follow up"-adj-0,"Follow-up"-tx-21-"follow up"-adj-0,"Follow-up"-tx-9-"follow up"-adj-0,"Follow-up"-tx-8-"follow up"-adj-0,"Follow-up"-tx-7-"FOLLOW UP"-adj-1]|TX|4271/9;4193/9;4039/9;1809/9;1713/9;1658/9|
00000000|MMI|22.71|follow-up|C1522577|[hlca]|["Follow Up"-tx-23-"follow up"-adj-0,"Follow Up"-tx-22-"Follow up"-adj-0,"Follow Up"-tx-21-"follow up"-adj-0,"Follow Up"-tx-9-"follow up"-adj-0,"Follow Up"-tx-8-"follow up"-adj-0,"Follow Up"-tx-7-"FOLLOW UP"-adj-0]|TX|4271/9;4193/9;4039/9;1809/9;1713/9;1658/9|
00000000|MMI|22.38|Ambulation|C0945826|[orgf]|["Ambulation"-tx-7-"ambulation"-noun-0]|TX|1638/10|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|22.38|Walking (activity)|C0080331|[dora]|["Ambulation"-tx-7-"ambulation"-noun-0]|TX|1638/10|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|22.37|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-9-"Treatment"-noun-0]|TX|2385/9|x.x.x.x.x.x.x
00000000|MMI|22.30|Oral|C0442027|[spco]|["PO"-tx-6-"PO"-noun-0,"PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[1223/2],[1320/2],[1480/2];938/2;725/2;545/2|
00000000|MMI|20.95|Lopressor|C0700776|[orch,phsu]|["Lopressor"-tx-13-"lopressor"-noun-0]|TX|3138/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-21-"CONDITION"-noun-0,"condition"-tx-9-"Conditions"-noun-0]|TX|4006/9;2333/10|C23.550.288
00000000|MMI|19.67|Abdomen|C0000726|[blor]|["abd"-tx-17-"abd"-noun-0,"abd"-tx-14-"abd"-noun-0]|TX|3537/3;3214/3|A01.923.047
00000000|MMI|19.23|Deficiency of glucose-6-phosphate dehydrogenase|C2939465|[dsyn]|["G6PD DEFICIENCY"-tx-4-"G6PD DEFICIENCY"-noun-0]|TX|661/15|C15.378.071.141.150.480;C16.320.070.480;C16.320.565.202.402;C18.452.648.202.402
00000000|MMI|19.22|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-4-"ATENOLOL"-noun-0]|TX|710/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|19.22|Gastroesophageal reflux disease|C0017168|[dsyn]|["GERD"-tx-9-"GERD"-noun-0]|TX|2641/4|C06.405.117.119.500.484
00000000|MMI|19.22|Hypercholesterolemia|C0020443|[dsyn]|["HYPERCHOLESTEROLEMIA"-tx-9-"Hypercholesterolemia"-noun-0]|TX|2591/20|C18.452.584.500.500.396
00000000|MMI|19.20|Creatine Kinase|C0010287|[aapp,enzy]|["CK"-tx-23-"CK"-noun-0]|TX|4242/2|D08.811.913.696.640.150
00000000|MMI|19.17|Hospital admission|C0184666|[hlca]|["Admission to hospital"-tx-20-"admission to hospital"-noun-0,"admitted"-tx-17-"admitted"-verb-0,"Admission"-tx-9-"Admission"-noun-0,"Admit"-tx-9-"ADMIT"-verb-0,"admitted"-tx-9-"admitted"-verb-0]|TX|3947/12,3964/8;3343/8;2283/9;2164/5;2869/8|
00000000|MMI|19.05|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-25-"DISCHARGE"-noun-0,"Discharge"-tx-21-"DISCHARGE"-noun-0,"Discharge"-tx-9-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4388/9;3996/9;2226/9;470/9;174/9|
00000000|MMI|19.05|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-25-"DISCHARGE"-noun-0,"Discharge"-tx-21-"DISCHARGE"-noun-0,"Discharge"-tx-9-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4388/9;3996/9;2226/9;470/9;174/9|
00000000|MMI|18.91|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-23-"call"-verb-0,"Call"-tx-22-"call"-verb-0,"Call"-tx-10-"called"-verb-0,"Call"-tx-9-"call"-noun-0,"Call"-tx-8-"call"-noun-0]|TX|4262/4;4084/4;2999/6;1798/4;1702/4|
00000000|MMI|18.91|Decision|C0679006|[menp]|["Call"-tx-23-"call"-verb-0,"Call"-tx-22-"call"-verb-0,"Call"-tx-10-"called"-verb-1,"Call"-tx-9-"call"-noun-0,"Call"-tx-8-"call"-noun-0]|TX|4262/4;4084/4;2999/6;1798/4;1702/4|
00000000|MMI|18.74|30%|C3842588|[fndg]|["30%"-tx-25-"30"-fraction-0,"30%"-tx-6-"30"-fraction-0,"30%"-tx-5-"30"-fraction-0,"30%"-tx-3-"30"-fraction-0,"30%"-tx-2-"30"-fraction-0]|TX|4363/2;1266/2;1045/2;589/2;280/2|
00000000|MMI|18.57|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-6-"MG"-noun-0,"Mg++"-tx-4-"mg"-noun-0,"Mg++"-tx-3-"MG"-noun-0]|TX|1477/2;[813/2],[871/2],[893/2];542/2|
00000000|MMI|18.57|Milligram percent|C1960952|[qnco]|["mg %"-tx-6-"MG"-noun-0,"mg %"-tx-4-"mg"-noun-0,"mg %"-tx-3-"MG"-noun-0]|TX|1477/2;[813/2],[871/2],[893/2];542/2|
00000000|MMI|18.57|mg/dL|C0439269|[qnco]|["mg%"-tx-6-"MG"-noun-0,"mg%"-tx-4-"mg"-noun-0,"mg%"-tx-3-"MG"-noun-0]|TX|1477/2;[813/2],[871/2],[893/2];542/2|
00000000|MMI|17.80|Angioedema|C0002994|[patf]|["Angiooedema"-tx-11-"Angioedema"-noun-0]|TX|3032/10|C14.907.079;C17.800.862.945.066;C20.543.480.904.066
00000000|MMI|17.80|Coronary Arteriosclerosis|C0010054|[dsyn]|["cardiac ischemia"-tx-20-"cardiac ischemia"-noun-1]|TX|3857/16|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-9-"Lisinopril"-noun-0]|TX|2009/10|D12.644.456.345.600
00000000|MMI|17.80|Macrodantin|C0700187|[orch,phsu]|["Macrodantin"-tx-9-"Macrodantin"-noun-0]|TX|2056/11|D02.640.600.566;D03.383.312.649.566
00000000|MMI|17.80|Nitrofurantoin|C0028156|[orch,phsu]|["NITROFURANTOIN"-tx-9-"nitrofurantoin"-noun-0]|TX|2070/14|D02.640.600.566;D03.383.312.649.566
00000000|MMI|16.30|Hematocrit procedure|C0018935|[lbpr]|["HCT"-tx-15-"Hct"-noun-0]|TX|3288/3|E01.370.225.625.400;E05.200.625.400;G09.188.370.374
00000000|MMI|16.30|Hemopoietic stem cell transplant|C0472699|[topp]|["HCT"-tx-15-"Hct"-noun-0]|TX|3288/3|E04.936.225.687.500
00000000|MMI|16.30|Synthroid|C0728762|[aapp,phsu]|["Synthroid"-tx-6-"SYNTHROID"-noun-0]|TX|1181/9|D06.472.931.812;D12.125.072.050.767
00000000|MMI|16.23|In Blood|C0005768|[bdsu]|["BLOOD"-tx-9-"blood"-noun-0]|TX|1888/5|x.x.x.x.x
00000000|MMI|16.21|Subdural space|C0038541|[bsoj]|["Subdural"-tx-9-"SUBDURAL"-adj-0]|TX|2457/8|A08.186.566.395.687
00000000|MMI|16.10|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-6-"Food/Drug Interaction"-noun-0]|TX|1487/21|G07.690.773.968.511
00000000|MMI|16.09|Ivory Coast|C0022326|[geoa]|["IV"-tx-9-"Iv"-noun-0]|TX|1919/2|Z01.058.290.190.272
00000000|MMI|15.94|Negation|C1518422|[ftcn]|["Not"-tx-20-"not"-adv-0,"Not"-tx-10-"not"-adv-0,"Not"-tx-9-"NOT"-adv-0]|TX|[3842/3],[3885/3];2958/3;2716/3|
00000000|MMI|15.43|Order (action)|C1705178|[acty]|["Order"-tx-25-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4398/6;1302/5;337/5;184/6|
00000000|MMI|15.43|Order (arrangement)|C1705176|[qlco]|["Order"-tx-25-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4398/6;1302/5;337/5;184/6|
00000000|MMI|15.43|Order (document)|C1705175|[inpr]|["Order"-tx-25-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4398/6;1302/5;337/5;184/6|
00000000|MMI|15.43|Order (taxonomic)|C1705177|[clas]|["Order"-tx-25-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4398/6;1302/5;337/5;184/6|
00000000|MMI|15.43|Permutation|C1882348|[qlco]|["Order"-tx-25-"ORDERS"-verb-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-2-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4398/6;1302/5;337/5;184/6|
00000000|MMI|15.43|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-25-"ORDERS"-verb-0,"ORDER"-tx-6-"order"-noun-0,"ORDER"-tx-2-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|4398/6;1302/5;337/5;184/6|
00000000|MMI|15.37|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-22-"allergy"-noun-0,"Allergy"-tx-18-"ALLERGY"-noun-0,"Allergy"-tx-9-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|4064/7;3578/7;1910/7;631/7|
00000000|MMI|15.37|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-22-"allergy"-noun-0,"Allergy"-tx-18-"ALLERGY"-noun-0,"Allergy"-tx-9-"ALLERGY"-noun-0,"Allergy"-tx-4-"ALLERGY"-noun-0]|TX|4064/7;3578/7;1910/7;631/7|
00000000|MMI|15.37|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-22-"allergy"-noun-0,"ALLERGY"-tx-18-"ALLERGY"-noun-0,"ALLERGY"-tx-9-"ALLERGY"-noun-0,"ALLERGY"-tx-4-"ALLERGY"-noun-0]|TX|4064/7;3578/7;1910/7;631/7|
00000000|MMI|15.31|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-23-"Pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-6-"pt"-noun-0]|TX|4256/2;3878/2;[1167/2],[1431/2]|
00000000|MMI|15.31|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-23-"Pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-6-"pt"-noun-0]|TX|4256/2;3878/2;[1167/2],[1431/2]|
00000000|MMI|15.12|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-18-"instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0,"instructions"-tx-5-"Instructions"-noun-0,"instructions"-tx-4-"Instructions"-noun-0]|TX|3718/11;1509/11;945/12;777/12|
00000000|MMI|15.12|Instructions|C1442085|[idcn]|["instruction"-tx-18-"instruction"-noun-0,"instruction"-tx-6-"Instruction"-noun-0,"Instructions"-tx-5-"Instructions"-noun-0,"Instructions"-tx-4-"Instructions"-noun-0]|TX|3718/11;1509/11;945/12;777/12|
00000000|MMI|14.80|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-22-"Dr"-noun-0,"DR"-tx-21-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4212/2;4054/2;1772/2;1686/2|
00000000|MMI|14.80|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-22-"Dr"-noun-0,"DR"-tx-21-"Dr"-noun-0,"DR"-tx-8-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4212/2;4054/2;1772/2;1686/2|
00000000|MMI|14.80|Doctor - Title|C2348314|[cnce]|["Dr."-tx-22-"Dr"-noun-0,"Dr."-tx-21-"Dr"-noun-0,"Dr."-tx-8-"Dr"-noun-0,"Dr."-tx-7-"Dr"-noun-0]|TX|4212/2;4054/2;1772/2;1686/2|
00000000|MMI|14.64|Blood group antigen D|C0073187|[aapp,imft]|["D NOS"-tx-17-"d"-noun-0]|TX|3496/1|x.x.x.x
00000000|MMI|14.64|Consultation|C0009818|[hlca]|["consulted"-tx-18-"consulted"-verb-0]|TX|3598/9|N04.452.758.849
00000000|MMI|14.64|Dairy Products|C0010947|[food]|["Dairy Products"-tx-9-"Dairy products"-noun-0]|TX|2134/14|G07.203.300.350;J02.500.350
00000000|MMI|14.64|Diet|C0012155|[food]|["Diet"-tx-7-"DIET"-noun-0]|TX|1570/4|G07.203.650.240
00000000|MMI|14.64|Hematochezia|C0018932|[fndg]|["BRBPR"-tx-12-"BRBPR"-noun-1]|TX|3081/5|C06.405.227;C23.550.414.788
00000000|MMI|14.38|Discontinued|C1444662|[fndg]|["D/C"-tx-22-"d/c"-noun-0,"D/C"-tx-18-"d/c"-noun-0,"D/C"-tx-2-"D/C"-noun-0,"DIS"-tx-1-"DIS"-noun-0]|TX|4179/3;3714/3;333/3;92/3|
00000000|MMI|13.61|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-18-"instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0]|TX|3718/11;1509/11|I02.903
00000000|MMI|13.24|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-3-"Home services"-noun-0]|TX|453/4,461/8|N04.452.758.307
00000000|MMI|13.14|Etiology|C1314792|[ftcn]|["Etiology"-tx-18-"etiology"-noun-0]|TX|3634/8|N05.715.350.200;N06.850.490.625
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-21-"PLAN"-noun-0]|TX|4030/4|C10.228.140.744
00000000|MMI|13.03|Rabbi|C0684010|[prog]|["R."-tx-9-"R"-noun-0]|TX|2725/1|M01.526.799.500
00000000|MMI|12.96|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-15-"Baseline"-noun-0]|TX|3279/8|x.x.x.x
00000000|MMI|12.96|Christmas Island|C0006888|[geoa]|["CXR"-tx-16-"CXR"-noun-0]|TX|3300/3|Z01.639.100;Z01.678.100.373
00000000|MMI|12.91|Walkers|C0043016|[medd]|["Walker"-tx-7-"walker"-noun-0]|TX|1651/6|E07.858.442.980
00000000|MMI|12.90|Diarrhea|C0011991|[sosy]|["DIARRHOEA"-tx-17-"diarrhea"-noun-1]|TX|3567/8|C23.888.821.214
00000000|MMI|12.89|Oral cavity|C0226896|[bsoj]|["MOUTH"-tx-4-"mouth"-noun-0]|TX|819/5|A01.456.505.631;A03.556.500;A14.549
00000000|MMI|12.89|4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine|C0245203|[bacs,orch]|["APPT"-tx-8-"appt"-noun-0]|TX|1723/4|x.x.x.x
00000000|MMI|12.89|Evaluation|C0220825|[hlca]|["Evaluation"-tx-2-"evaluation"-noun-0]|TX|317/10|E05.337;N05.715.360.335
00000000|MMI|12.89|Honduras|C0019905|[geoa]|["HO"-tx-2-"HO"-noun-0]|TX|314/2|Z01.107.169.534
00000000|MMI|12.89|Panama|C0030266|[geoa]|["PM"-tx-2-"PM"-adj-0]|TX|295/2|Z01.107.169.772
00000000|MMI|12.88|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-22-"PCP"-noun-0]|TX|4208/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-9-"Complications"-noun-0]|TX|2359/13|x.x.x
00000000|MMI|11.49|Diet therapy|C0012159|[hlca]|["Diet"-tx-7-"DIET"-noun-0]|TX|1570/4|E02.642.249
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-9-"PROCEDURES"-noun-0]|TX|2674/10|x.x.x
00000000|MMI|11.49|Myocardial Ischemia|C0151744|[dsyn]|["Cardiac ischemia"-tx-20-"cardiac ischemia"-noun-1]|TX|3857/16|C14.280.647;C14.907.585
00000000|MMI|11.03|day|C0439228|[tmco]|["DAY"-tx-4-"day"-noun-0,"DAYS"-tx-4-"days"-noun-0]|TX|[881/3],[904/3];843/4|
00000000|MMI|11.02|Chest discomfort|C0235710|[sosy]|["CHEST DISCOMFORT"-tx-20-"chest discomfort"-noun-1,"CHEST DISCOMFORT"-tx-19-"chest discomfort"-noun-0,"CHEST DISCOMFORT"-tx-9-"chest discomfort"-noun-0]|TX|3901/16;3761/16;2931/16|
00000000|MMI|10.92|Admission activity|C0809949|[hlca]|["Admitted"-tx-17-"admitted"-verb-0,"Admission"-tx-9-"Admission"-noun-0,"Admitted"-tx-9-"admitted"-verb-0]|TX|3343/8;2283/9;2869/8|
00000000|MMI|10.90|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-6-"Reason"-noun-0,"Reason"-tx-4-"Reason"-noun-0]|TX|[1146/6],[1410/6];677/6|
00000000|MMI|10.84|Additional|C1524062|[ftcn]|["Added"-tx-6-"added"-verb-0,"Added"-tx-5-"added"-verb-0,"Added"-tx-3-"added"-verb-0]|TX|1255/5;1034/5;578/5|
00000000|MMI|10.82|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-19-"CAD"-noun-0,"CAD"-tx-9-"CAD"-adj-0]|TX|3734/3;[2555/3],[2830/3]|
00000000|MMI|10.66|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-22-"d/c"-noun-0,"D.C."-tx-18-"d/c"-noun-0,"D.C."-tx-2-"D/C"-noun-0]|TX|4179/3;3714/3;333/3|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-9-"DIAGNOSIS"-noun-0]|TX|[2170/9],[2323/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-9-"DIAGNOSIS"-noun-0]|TX|[2170/9],[2323/9]|
00000000|MMI|10.42|See|C1947903|[acty]|["See"-tx-22-"see"-verb-0,"See"-tx-18-"see"-verb-0]|TX|4175/3;3710/3|
00000000|MMI|10.42|Subject Continuance|C2826258|[evnt]|["CONT"-tx-22-"cont"-verb-0,"CONT"-tx-17-"cont"-verb-0]|TX|4119/4;3511/4|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-25-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|4398/6;184/6|
00000000|MMI|10.28|Drawings (art)|C0013113|[inpr]|["Draw"-tx-20-"drawn"-verb-0]|TX|3801/5|V01.185.625;V02.700.300
00000000|MMI|9.99|Etiology aspects|C0015127|[ftcn]|["etiology"-tx-18-"etiology"-noun-0]|TX|3634/8|x.x.x
00000000|MMI|9.99|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-5-"tabs"-noun-0]|TX|1002/4|D26.255.830
00000000|MMI|9.94|Filtering Surgery|C0242673|[topp]|["filter operations"-tx-9-"filter OPERATIONS"-noun-0]|TX|2584/6,2659/10|E04.540.450
00000000|MMI|9.92|Blood|C0005767|[tisu]|["Blood"-tx-9-"blood"-noun-0]|TX|1888/5|A12.207.152;A15.145
00000000|MMI|9.81|Netherlands|C0027778|[geoa]|["NL"-tx-14-"nl"-noun-0]|TX|3189/2|Z01.542.651
00000000|MMI|9.76|Tracheostomy procedure|C0040590|[topp]|["Tracheostomies"-tx-9-"tracheostomies"-noun-0]|TX|2489/14|E02.041.750;E04.579.935;E04.580.900;E04.928.780
00000000|MMI|9.75|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-9-"HTN"-noun-0]|TX|2612/3|C14.907.489
00000000|MMI|9.75|Hypotension|C0020649|[fndg]|["HYPOTENSION"-tx-9-"Hypotension"-noun-0]|TX|2616/11|C14.907.514
00000000|MMI|9.75|Polycythemia|C0032461|[dsyn]|["POLYCYTHEMIA"-tx-9-"Polycythemia"-noun-0]|TX|2628/12|C15.378.738
00000000|MMI|9.74|Hospital Units|C0019988|[hcro,mnob]|["Hospital Units"-tx-9-"units HOSPITAL"-noun-0]|TX|2732/5,2758/8|N02.278.388
00000000|MMI|9.74|Cocos (Keeling) Islands|C0009212|[geoa]|["CK"-tx-23-"CK"-noun-0]|TX|4242/2|Z01.639.520
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-9-"Infections"-noun-0]|TX|2346/10|C01.539
00000000|MMI|8.34|Radiation|C0851346|[npop]|["Radiations"-tx-11-"radiations"-noun-0]|TX|3065/10|G01.750
00000000|MMI|7.70|per day|C0439505|[tmco]|["/day"-tx-4-"day"-noun-0]|TX|[881/3],[904/3]|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-21-"CONDITION"-noun-0,"Condition"-tx-9-"Conditions"-noun-0]|TX|4006/9;2333/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-21-"CONDITION"-noun-0,"Condition"-tx-9-"Conditions"-noun-0]|TX|4006/9;2333/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-21-"CONDITION"-noun-0,"Condition"-tx-9-"Conditions"-noun-0]|TX|4006/9;2333/10|
00000000|MMI|7.54|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-5-"Instructions"-noun-0,"Instructions"-tx-4-"Instructions"-noun-0]|TX|945/12;777/12|
00000000|MMI|7.45|Afternoon|C0439550|[tmco]|["Afternoon"-tx-9-"afternoon"-noun-0,"Afternoon"-tx-8-"afternoon"-noun-0]|TX|1836/9;1733/9|
00000000|MMI|7.45|Report (document)|C0684224|[inpr]|["Reports"-tx-19-"reports"-noun-0,"Reported"-tx-17-"reported"-verb-0]|TX|3750/7;3459/8|
00000000|MMI|7.45|Reporting|C0700287|[hlca]|["reports"-tx-19-"reports"-noun-0,"Reported"-tx-17-"reported"-verb-0]|TX|3750/7;3459/8|
00000000|MMI|7.40|Coating (film)|C1522408|[qlco]|["Coated"-tx-3-"COATED"-adj-0]|TX|[505/6],[530/6]|
00000000|MMI|7.40|Enteral|C1304890|[spco]|["Enteric"-tx-3-"ENTERIC"-adj-0]|TX|[497/7],[522/7]|
00000000|MMI|7.31|Cardiac enzymes|C0443763|[aapp,enzy]|["Cardiac enzymes"-tx-20-"Cardiac enzymes"-noun-0,"Cardiac enzymes"-tx-14-"Cardiac enzymes"-noun-0]|TX|3780/15;3257/15|
00000000|MMI|7.31|Negative - answer|C3853545|[qlco]|["NEG"-tx-16-"neg"-noun-0,"NEG"-tx-14-"neg"-noun-0]|TX|3304/3;3273/3|
00000000|MMI|7.31|Then|C1883708|[tmco]|["Then"-tx-4-"then"-adv-0]|TX|[802/4],[850/4]|
00000000|MMI|7.31|Interaction|C1704675|[ftcn]|["Interaction"-tx-6-"INTERACTION"-noun-0]|TX|[1098/11],[1362/11]|
00000000|MMI|7.28|Alert|C3665546|[ftcn]|["Alert"-tx-5-"Alert"-verb-0,"Alert"-tx-3-"Alert"-noun-0]|TX|1007/5;551/5|
00000000|MMI|7.28|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-5-"Alert"-verb-0,"Alert"-tx-3-"Alert"-noun-0]|TX|1007/5;551/5|
00000000|MMI|7.28|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-5-"Alert"-verb-0,"ALERT"-tx-3-"Alert"-noun-0]|TX|1007/5;551/5|
00000000|MMI|7.27|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-9-"ASA"-noun-0,"ASA"-tx-3-"ASA"-noun-0]|TX|2441/3;493/3|
00000000|MMI|7.27|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AFib"-tx-14-"afib"-noun-0,"AFib"-tx-9-"AFIB"-noun-0]|TX|3199/4;2422/4|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-23-"summary"-noun-0,"Summary"-tx-2-"SUMMARY"-noun-0]|TX|4306/7;362/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-23-"summary"-noun-0,"summary"-tx-2-"SUMMARY"-noun-0]|TX|4306/7;362/7|
00000000|MMI|7.21|+5|C0728893|[qnco]|["+5"-tx-25-"5"-fraction-0,"+5"-tx-2-"5"-fraction-0]|TX|4361/1;278/1|
00000000|MMI|7.21|>5|C0439084|[qnco]|[">5"-tx-25-"5"-fraction-0,">5"-tx-2-"5"-fraction-0]|TX|4361/1;278/1|
00000000|MMI|7.16|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-13-"ED"-noun-0,"ED"-tx-9-"ED"-noun-0]|TX|3130/2;2887/2|
00000000|MMI|7.14|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-9-"call"-noun-0,"c all"-tx-8-"call"-noun-0]|TX|1798/4;1702/4|
00000000|MMI|7.11|10%|C3842590|[fndg]|["10%"-tx-1-"10"-fraction-0]|TX|[114/2],[156/2]|
00000000|MMI|7.07|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-9-"MI"-noun-0,"MI"-tx-9-"mi"-noun-0]|TX|2563/2;2840/2|
00000000|MMI|7.06|Data Validation Test Document|C3899446|[inpr]|["DVT"-tx-9-"DVT"-noun-0]|TX|[2529/3],[2574/3]|
00000000|MMI|7.06|Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal|C2926618|[clna]|["DVT"-tx-9-"DVT"-noun-0]|TX|[2529/3],[2574/3]|
00000000|MMI|7.05|Treating|C1522326|[ftcn]|["Treated"-tx-13-"treated"-verb-0,"Treatment"-tx-9-"Treatment"-noun-0]|TX|3115/7;2385/9|
00000000|MMI|7.03|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-9-"RESUME"-noun-0,"Resume"-tx-7-"Resume"-noun-0]|TX|2748/6;1614/6|
00000000|MMI|7.03|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-9-"RESUME"-noun-0,"Resume"-tx-7-"Resume"-noun-0]|TX|2748/6;1614/6|
00000000|MMI|7.03|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-9-"RESUME"-noun-0,"resume"-tx-7-"Resume"-noun-0]|TX|2748/6;1614/6|
00000000|MMI|7.02|Code|C0805701|[inpr]|["CODE"-tx-3-"CODE"-noun-0,"CODE"-tx-3-"code"-noun-0]|TX|417/4;435/4|
00000000|MMI|7.02|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-3-"CODE"-noun-0,"Code"-tx-3-"code"-noun-0]|TX|417/4;435/4|
00000000|MMI|7.01|Fresh frozen plasma|C0016709|[bdsu]|["FFP"-tx-17-"FFP"-noun-0,"FFP"-tx-9-"FFP"-noun-0]|TX|3422/3;2738/3|
00000000|MMI|7.01|Unit|C0439148|[qnco]|["UNITS"-tx-17-"units"-noun-0,"UNITS"-tx-9-"units"-noun-0]|TX|3416/5;2732/5|
00000000|MMI|7.01|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-17-"units"-noun-0,"Units"-tx-9-"units"-noun-0]|TX|3416/5;2732/5|
00000000|MMI|7.01|Unit of Measure|C1519795|[qnco]|["Units"-tx-17-"units"-noun-0,"Units"-tx-9-"units"-noun-0]|TX|3416/5;2732/5|
00000000|MMI|6.99|Serious|C0205404|[qlco]|["Serious"-tx-6-"SERIOUS"-adj-0]|TX|[1090/7],[1354/7]|
00000000|MMI|6.98|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-17-"abd"-noun-0,"ABD"-tx-14-"abd"-noun-0]|TX|3537/3;3214/3|
00000000|MMI|6.98|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-17-"abd"-noun-0,"ABD"-tx-14-"abd"-noun-0]|TX|3537/3;3214/3|
00000000|MMI|6.98|Diffuse|C0205219|[qlco]|["DIFFUSE"-tx-17-"diffuse"-adj-0,"DIFFUSE"-tx-14-"diffuse"-adj-0]|TX|3529/7;3206/7|
00000000|MMI|6.97|Mild (qualifier value)|C2945599|[qlco]|["MILD"-tx-17-"mild"-adj-0,"Minimal"-tx-13-"minimal"-adj-0]|TX|3524/4;3159/7|
00000000|MMI|6.95|Twice (Numerical Qualifier)|C1948050|[qnco]|["Twice"-tx-4-"twice"-adv-0]|TX|[825/5],[896/5]|
00000000|MMI|6.95|Twice - dosing instruction fragment|C1720725|[inpr]|["Twice"-tx-4-"twice"-adv-0]|TX|[825/5],[896/5]|
00000000|MMI|6.92|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-9-"multiple"-adj-0]|TX|[2508/8],[2794/8]|
00000000|MMI|6.61|Intubation|C0021925|[topp]|["Intubations"-tx-9-"intubations"-noun-0]|TX|2517/11|E02.585;E05.497
00000000|MMI|5.18|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-7-"ACTIVITY"-noun-0]|TX|1604/8|
00000000|MMI|5.18|Abdominal tenderness|C0232498|[sosy]|["ABDOMINAL TENDERNESS"-tx-9-"abdominal tenderness"-noun-0]|TX|2906/20|
00000000|MMI|5.18|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-2-"Service"-noun-0]|TX|243/7|
00000000|MMI|5.18|Active|C0205177|[ftcn]|["Activity"-tx-7-"ACTIVITY"-noun-0]|TX|1604/8|
00000000|MMI|5.18|Activities|C0441655|[acty]|["ACTIVITY"-tx-7-"ACTIVITY"-noun-0]|TX|1604/8|
00000000|MMI|5.18|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-7-"ACTIVITY"-noun-1]|TX|1604/8|
00000000|MMI|5.18|Additional comments|C1830770|[fndg]|["Additional comments"-tx-21-"ADDITIONAL COMMENTS"-noun-0]|TX|3975/19|
00000000|MMI|5.18|Adult female goat|C3668950|[mamm]|["Doe"-tx-11-"DOE"-noun-0]|TX|3056/3|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-9-"affecting"-verb-0]|TX|2375/9|
00000000|MMI|5.18|Alternating|C0332270|[ftcn]|["Alternating"-tx-4-"alternating"-verb-0]|TX|855/11|
00000000|MMI|5.18|Antimicrobial susceptibility|C0427965|[fndg]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|644/11|
00000000|MMI|5.18|Basal Diet|C2983588|[food]|["DIET"-tx-7-"DIET"-noun-0]|TX|1570/4|
00000000|MMI|5.18|CR2 wt Allele|C3539604|[gngm]|["CR"-tx-15-"Cr"-noun-0]|TX|3296/2|
00000000|MMI|5.18|Changed status|C0443172|[qnco]|["Changed"-tx-18-"changed"-verb-0]|TX|3679/7|
00000000|MMI|5.18|Changing|C0392747|[ftcn]|["Changed"-tx-18-"changed"-verb-0]|TX|3679/7|
00000000|MMI|5.18|Checking (action)|C1283174|[acty]|["Check"-tx-9-"check"-verb-0]|TX|1878/5|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-9-"Complications"-noun-0]|TX|2359/13|
00000000|MMI|5.18|Creatinine measurement|C0201975|[lbpr]|["Cr"-tx-15-"Cr"-noun-0]|TX|3296/2|
00000000|MMI|5.18|Department of Energy|C1511776|[prog]|["DOE"-tx-11-"DOE"-noun-0]|TX|3056/3|
00000000|MMI|5.18|Diagnostic Sensitivity|C1511883|[qnco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|644/11|
00000000|MMI|5.18|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-7-"DIET"-noun-0]|TX|1570/4|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|140/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|140/14|
00000000|MMI|5.18|Dyspnea on exertion|C0231807|[sosy]|["DOE"-tx-11-"DOE"-noun-1]|TX|3056/3|
00000000|MMI|5.18|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-7-"ACTIVITY"-noun-0]|TX|1604/8|
00000000|MMI|5.18|Fexofenadine hydrochloride|C0771752|[orch,phsu]|["Fexofenadine HCl"-tx-6-"FEXOFENADINE HCL"-noun-0]|TX|1455/16|
00000000|MMI|5.18|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1527/10|
00000000|MMI|5.18|Good|C0205170|[qlco]|["Well"-tx-17-"well"-adv-0]|TX|3450/4|
00000000|MMI|5.18|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1527/10|
00000000|MMI|5.18|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1527/10|
00000000|MMI|5.18|Including (qualifier)|C0332257|[ftcn]|["Including"-tx-9-"including"-verb-0]|TX|2820/9|
00000000|MMI|5.18|Incontinence|C0021167|[dsyn]|["INCONTINENCE"-tx-12-"incontinence"-noun-1]|TX|3092/12|
00000000|MMI|5.18|Increased Sensitivy|C2346484|[phpr]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|644/11|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-9-"PROCEDURES"-noun-0]|TX|2674/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-9-"affecting"-verb-0]|TX|2375/9|
00000000|MMI|5.18|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|480/11|
00000000|MMI|5.18|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|480/11|
00000000|MMI|5.18|N not otherwise specified Antibody|C0369718|[aapp,imft]|["N NOS"-tx-9-"n"-noun-0]|TX|2898/1|
00000000|MMI|5.18|N+ (tumor staging)|C0441922|[inpr]|["N+"-tx-9-"n"-noun-0]|TX|2898/1|
00000000|MMI|5.18|One|C0205447|[qnco]|["ONE"-tx-5-"one"-noun-0]|TX|989/3|
00000000|MMI|5.18|Percent Activity|C0439167|[qnco]|["% Activity"-tx-7-"ACTIVITY"-noun-0]|TX|1604/8|
00000000|MMI|5.18|Personality Sensitivity|C0312418|[menp]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|644/11|
00000000|MMI|5.18|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|480/11|D26
00000000|MMI|5.18|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-7-"ACTIVITY"-noun-0]|TX|1604/8|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-9-"PROCEDURES"-noun-0]|TX|2674/10|
00000000|MMI|5.18|Produces milk for human food|C3687582|[orga]|["Dairy"-tx-7-"dairy"-noun-0]|TX|1592/5|
00000000|MMI|5.18|S prime|C2603362|[clna]|["S'"-tx-7-"("-noun-0]|TX|1679/1|
00000000|MMI|5.18|Services|C0557854|[ocac]|["Service"-tx-2-"Service"-noun-0]|TX|243/7|
00000000|MMI|5.18|Shortness of breath:-:Point in time:^Patient:-|C2707305|[clna]|["Shortness of breath"-tx-20-"shortness of breath"-noun-0]|TX|3921/19|
00000000|MMI|5.18|Signal Sensitivity|C2349185|[qlco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|644/11|
00000000|MMI|5.18|Software Service|C2825316|[mnob]|["Service"-tx-2-"Service"-noun-0]|TX|243/7|
00000000|MMI|5.18|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-7-"DIET"-noun-0]|TX|1570/4|
00000000|MMI|5.18|Statistical sensitivity|C0036667|[qnco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|644/11|
00000000|MMI|5.18|T prime|C2603360|[clna]|["T'"-tx-17-"t"-noun-0]|TX|3337/1|
00000000|MMI|5.18|TAMP|C0491932|[medd]|["TAMP"-tx-2-"Tamp"-verb-0]|TX|238/4|
00000000|MMI|5.18|Take|C1515187|[hlca]|["Take"-tx-5-"take"-verb-0]|TX|984/4|
00000000|MMI|5.18|Well|C3146287|[mnob]|["Well"-tx-17-"well"-adv-0]|TX|3450/4|
00000000|MMI|5.18|Wheat (Dietary)|C0043137|[food]|["WHEAT"-tx-7-"wheat"-noun-0]|TX|1579/5|
00000000|MMI|5.18|Wheat - grass (plant)|C1510495|[plnt]|["Wheat"-tx-7-"wheat"-noun-0]|TX|1579/5|
00000000|MMI|5.18|Wheat gluten|C3812405|[aapp,phsu]|["Wheat gluten"-tx-9-"Wheat/gluten"-noun-0]|TX|2151/12|
00000000|MMI|5.18|Wheat gluten extract|C2827346|[aapp,phsu]|["WHEAT GLUTEN"-tx-9-"Wheat/gluten"-noun-0]|TX|2151/12|
00000000|MMI|5.18|Wheat preparation|C1095911|[phsu]|["WHEAT"-tx-7-"wheat"-noun-0]|TX|1579/5|
00000000|MMI|5.18|per second|C0565930|[qnco]|["/s"-tx-7-"("-noun-0]|TX|1679/1|
00000000|MMI|5.18|stimulus sensitivity|C1522640|[qlco]|["Sensitivity"-tx-4-"SENSITIVITY"-noun-0]|TX|644/11|
00000000|MMI|5.18|sulfa|C0749139|[phsu]|["sulfa"-tx-9-"Sulfa"-noun-0]|TX|1938/5|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-9-"TREATMENTS/PROCEDURES"-noun-0]|TX|2692/21|
00000000|MMI|3.76|Mild pain|C0278138|[fndg]|["Mild pain"-tx-17-"mild pain"-noun-0]|TX|3524/4,3541/4|
00000000|MMI|3.75|3 Days|C1442459|[tmco]|["3 Days"-tx-4-"3 days"-noun-0]|TX|795/6|
00000000|MMI|3.75|Procaine hydrochloride|C0358490|[orch,phsu]|["procaine hcl"-tx-9-"procaine hcl"-noun-0]|TX|2114/12|
00000000|MMI|3.75|contrast dye|C0742795|[irda]|["contrast dyes"-tx-9-"contrast dyes"-noun-0]|TX|1922/13|
00000000|MMI|3.70|Diffuse pain|C0520963|[sosy]|["Diffuse pain"-tx-17-"diffuse pain"-noun-0]|TX|3529/7,3541/4|
00000000|MMI|3.68|ALYREF gene|C1425988|[gngm]|["REF"-tx-6-"ref"-noun-0]|TX|1325/3|
00000000|MMI|3.68|Allegra|C1110594|[orch,phsu]|["Allegra"-tx-6-"ALLEGRA"-noun-0]|TX|1445/7|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-2-"Attending"-noun-0]|TX|375/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-2-"Attending"-noun-0]|TX|375/9|
00000000|MMI|3.68|Filter (function)|C1704449|[cnce]|["Filter"-tx-9-"filter"-noun-0]|TX|2539/6|
00000000|MMI|3.68|Filter - medical device|C1875155|[medd]|["FILTER"-tx-9-"filter"-noun-0]|TX|2539/6|
00000000|MMI|3.68|Filter Device Component|C1704684|[mnob]|["Filter"-tx-9-"filter"-noun-0]|TX|2539/6|
00000000|MMI|3.68|Filters|C0180860|[mnob]|["Filter"-tx-9-"filter"-noun-0]|TX|2539/6|
00000000|MMI|3.68|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-23-"M"-noun-0]|TX|4341/1|
00000000|MMI|3.68|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-23-"M"-noun-0]|TX|4341/1|
00000000|MMI|3.68|Optical filter|C0581406|[medd]|["Filter"-tx-9-"filter"-noun-0]|TX|2539/6|
00000000|MMI|3.68|Science of Etiology|C1524003|[cnce]|["Etiology"-tx-18-"etiology"-noun-0]|TX|3634/8|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-3-"STATUS"-noun-0]|TX|422/6|
00000000|MMI|3.68|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-5-"tabs"-noun-0]|TX|1002/4|
00000000|MMI|3.68|filter information process|C1522664|[inpr]|["Filter"-tx-9-"filter"-noun-0]|TX|2539/6|
00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|98/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|98/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|125/13|
00000000|MMI|3.65|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-9-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2216/9,2236/9|
00000000|MMI|3.65|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-9-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2216/9,2236/9|
00000000|MMI|3.64|10 - 12|C3843787|[fndg]|["10 - 12"-tx-1-"10 12"-fraction-0]|TX|41/2,52/2|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-23-"ENTERED"-verb-0]|TX|4314/7|
00000000|MMI|3.64|Normal limits|C0442816|[qnco]|["Normal limits"-tx-20-"normal limits"-noun-0]|TX|3827/13|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|440/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|440/11|
00000000|MMI|3.63|Emotional tenderness|C0684239|[menp]|["tenderness"-tx-14-"tenderness"-noun-0]|TX|3218/10|
00000000|MMI|3.63|Sore to touch|C0234233|[sosy]|["TENDERNESS (NOS)"-tx-14-"tenderness"-noun-0]|TX|3218/10|
00000000|MMI|3.63|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-9-"DISCHARGE DIAGNOSIS"-noun-0]|TX|2226/19|
00000000|MMI|3.62|Episode of|C0332189|[tmco]|["Episode of"-tx-17-"episodes of"-noun-0]|TX|3555/11|
00000000|MMI|3.61|Feeling relief|C0564405|[fndg]|["Relief"-tx-13-"relief"-noun-0]|TX|3167/6|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-21-"PLAN"-noun-0]|TX|4030/4|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-21-"PLAN"-noun-0]|TX|4030/4|
00000000|MMI|3.61|peripheral blood|C0229664|[bdsu]|["BLOOD"-tx-9-"blood"-noun-0]|TX|1888/5|
00000000|MMI|3.61|Treated with|C0332293|[topp]|["Treated with"-tx-17-"treated with"-verb-0]|TX|3401/12|
00000000|MMI|3.60|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-9-"H/O"-noun-0]|TX|2453/3|
00000000|MMI|3.60|Day 2|C3842676|[fndg]|["Day 2"-tx-4-"day 2"-noun-0]|TX|833/3,841/1|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-25-"END"-noun-0]|TX|4381/3|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-9-"Responsible"-adj-0]|TX|2247/11|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-25-"END"-noun-0]|TX|4381/3|
00000000|MMI|3.59|metal working fluid|C0920584|[chvf]|["MWF"-tx-5-"MWF"-noun-0]|TX|980/3|
00000000|MMI|3.58|Today|C0310367|[antb,orch]|["Today"-tx-4-"Today"-noun-0]|TX|762/5|
00000000|MMI|3.58|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-4-"Today"-noun-0]|TX|762/5|
00000000|MMI|3.58|Danazol allergy|C0571670|[dsyn]|["Danazol allergy"-tx-22-"Danazol Allergy"-noun-0]|TX|4130/7,4151/7|
00000000|MMI|3.58|Electrocardiographic changes|C0855329|[fndg]|["ekg change"-tx-16-"changes EKG"-noun-1]|TX|3321/7,3332/3|
00000000|MMI|3.57|0%|C3842591|[fndg]|["0%"-tx-5-"0"-real_number-0]|TX|959/1|
00000000|MMI|3.57|R prime|C2603358|[clna]|["R'"-tx-9-"R"-noun-0]|TX|2725/1|
00000000|MMI|3.57|Right|C0205090|[spco]|["R-"-tx-9-"R"-noun-0]|TX|2725/1|
00000000|MMI|3.55|Conditional|C1701901|[qlco]|["Contingent"-tx-2-"CONTINGENT"-noun-0]|TX|298/10|
00000000|MMI|3.55|Decrease|C0547047|[qnco]|["Decrease"-tx-17-"decrease"-noun-0]|TX|3470/8|
00000000|MMI|3.55|Reduced|C0392756|[qlco]|["Decrease"-tx-17-"decrease"-noun-0]|TX|3470/8|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-2-"USED"-verb-0]|TX|346/4|
00000000|MMI|3.55|Clinical Trial Final Report|C3889645|[inpr]|["Reports"-tx-19-"reports"-noun-0]|TX|3750/7|
00000000|MMI|3.55|Hereditary|C0439660|[ftcn]|["HEREDITARY"-tx-17-"Hereditary"-adj-0]|TX|3375/10|
00000000|MMI|3.51|Digoxin 0.125 MG|C0985542|[clnd]|["Digoxin 0.125 MG"-tx-5-"DIGOXIN 0.125 MG"-noun-0]|TX|921/16|
00000000|MMI|3.50|Baseline|C1442488|[qnco]|["Baseline"-tx-15-"Baseline"-noun-0]|TX|3279/8|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-9-"Causing"-adj-0]|TX|2275/7|
00000000|MMI|3.50|Definite|C0439544|[qlco]|["Definite"-tx-4-"DEFINITE"-adj-0]|TX|622/8|
00000000|MMI|3.50|Definitely Related to Intervention|C1704787|[qlco]|["Definite"-tx-4-"DEFINITE"-adj-0]|TX|622/8|
00000000|MMI|3.50|Half|C2825407|[qnco]|["Half"-tx-5-"half"-adv-0]|TX|997/4|
00000000|MMI|3.50|Medical Examination|C0582103|[hlca]|["Exam"-tx-14-"EXAM"-noun-0]|TX|3176/4|
00000000|MMI|3.50|Per Nanoliter|C3892223|[qnco]|["/nL"-tx-14-"nl"-noun-0]|TX|3189/2|
00000000|MMI|3.50|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-16-"CXR"-noun-0]|TX|3300/3|
00000000|MMI|3.50|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-18-"likely"-adj-0]|TX|3627/6|
00000000|MMI|3.50|Probably|C0750492|[idcn]|["Likely"-tx-18-"likely"-adj-0]|TX|3627/6|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-2-"YES"-noun-0]|TX|371/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-2-"YES"-noun-0]|TX|371/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-23-"dictated"-adj-0]|TX|4297/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-23-"dictated"-adj-0]|TX|4297/8|
00000000|MMI|3.50|nanolitre|C0560008|[qnco]|["nL"-tx-14-"nl"-noun-0]|TX|3189/2|
00000000|MMI|3.48|mg/mg|C1319635|[qnco]|["mg/mg"-tx-4-"MG MG"-noun-0]|TX|722/2,743/2|
00000000|MMI|3.48|Full|C0443225|[qlco]|["Full"-tx-3-"Full"-adj-0]|TX|430/4|
00000000|MMI|3.47|50%|C3842586|[fndg]|["50%"-tx-6-"50"-integer-0]|TX|1216/2|
00000000|MMI|3.47|<50|C3843766|[fndg]|["<50"-tx-6-"50"-integer-0]|TX|1216/2|
00000000|MMI|3.47|Minimal|C0547040|[qlco]|["Minimal"-tx-13-"minimal"-adj-0]|TX|3159/7|
00000000|MMI|3.47|Minimum|C1524031|[qlco]|["MINIMAL"-tx-13-"minimal"-adj-0]|TX|3159/7|
00000000|MMI|3.47|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-21-"Stable"-adj-0]|TX|4017/6|
00000000|MMI|3.47|Stable status|C0205360|[qlco]|["STABLE"-tx-21-"Stable"-adj-0]|TX|4017/6|
00000000|MMI|3.47|microgram|C0439211|[qnco]|["mcg"-tx-6-"MCG"-noun-0]|TX|1219/3|
00000000|MMI|3.47|miscellaneous Crenarchaeota group|C3463985|[arch]|["MCG"-tx-6-"MCG"-noun-0]|TX|1219/3|
00000000|MMI|3.46|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-7-"regular exercise"-noun-0]|TX|1621/16|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|92/3|
00000000|MMI|3.46|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-14-"Labs"-noun-0]|TX|3241/4|
00000000|MMI|3.46|Primary|C0205225|[qlco]|["Principal"-tx-9-"PRINCIPAL"-adj-0]|TX|2216/9|
00000000|MMI|3.46|Son (person)|C0037683|[famg]|["Son"-tx-2-"Son"-noun-0]|TX|228/3|
00000000|MMI|3.46|Teaching principal|C0401925|[prog]|["Principal"-tx-9-"PRINCIPAL"-adj-0]|TX|2216/9|
00000000|MMI|3.45|Alternate days|C0558287|[tmco]|["QOD"-tx-5-"QOD"-adv-0]|TX|941/3|
00000000|MMI|3.45|Total abdominal hysterectomy|C0404079|[topp]|["tah"-tx-9-"TAH"-noun-0]|TX|2485/3|
00000000|MMI|3.45|60%|C3842585|[fndg]|["60%"-tx-6-"60"-integer-0]|TX|1474/2|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-9-"Study"-noun-0]|TX|2265/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-9-"Study"-noun-0]|TX|2265/5|
00000000|MMI|3.45|Administration procedure|C1533734|[topp]|["Treatment"-tx-9-"Treatment"-noun-0]|TX|2385/9|
00000000|MMI|3.45|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-9-"Treatment"-noun-0]|TX|2385/9|
00000000|MMI|3.45|LoDose|C0126119|[orch,phsu]|["LoDose"-tx-9-"lodose"-noun-0]|TX|2429/6|
00000000|MMI|3.45|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-9-"Treatment"-noun-0]|TX|2385/9|E02
00000000|MMI|3.45|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-9-"Treatment"-noun-0]|TX|2385/9|
00000000|MMI|3.45|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-9-"Treatment"-noun-0]|TX|2385/9|
00000000|MMI|3.45|Three times daily|C0556984|[tmco]|["TID"-tx-4-"TID"-noun-0]|TX|749/3|
00000000|MMI|3.45|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-4-"TID"-noun-0]|TX|749/3|
00000000|MMI|3.45|CHAF1A wt Allele|C3812373|[gngm]|["CAF"-tx-9-"CAF"-noun-0]|TX|2566/3|
00000000|MMI|3.45|Hypercholesterolemia result|C1522133|[fndg]|["Hypercholesterolemia"-tx-9-"Hypercholesterolemia"-noun-0]|TX|2591/20|
00000000|MMI|3.45|Hypotension Adverse Event|C3163620|[fndg]|["Hypotension"-tx-9-"Hypotension"-noun-0]|TX|2616/11|
00000000|MMI|3.45|Place|C0442504|[spco]|["Place"-tx-9-"place"-noun-0]|TX|2549/5|
00000000|MMI|3.45|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-9-"place"-noun-0]|TX|2549/5|
00000000|MMI|3.45|put - instruction imperative|C1882509|[acty]|["Place"-tx-9-"place"-noun-0]|TX|2549/5|
00000000|MMI|3.44|Due to|C0678226|[ftcn]|["Due To"-tx-19-"Due to"-prep-0]|TX|3739/6|
00000000|MMI|3.44|Next appointment|C1272171|[fndg]|["Next appointment"-tx-9-"appointment next"-noun-0]|TX|1853/16|
00000000|MMI|3.44|Diarrhea Adverse Event|C1963091|[fndg]|["Diarrhea"-tx-17-"diarrhea"-noun-1]|TX|3567/8|
00000000|MMI|3.44|Hospital course|C0489547|[fndg]|["Hospital course"-tx-9-"HOSPITAL COURSE"-noun-1]|TX|2758/15|
00000000|MMI|3.44|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-9-"HOSPITAL COURSE"-noun-0]|TX|2758/15|
00000000|MMI|3.43|Clinical Trials, Monitoring|C1516647|[resa]|["monitoring"-tx-23-"monitoring"-noun-0]|TX|4228/10|
00000000|MMI|3.43|Entire mouth region|C1267547|[blor]|["Mouth, NOS"-tx-4-"mouth"-noun-0]|TX|819/5|
00000000|MMI|3.43|Entire oral cavity|C1278910|[blor]|["Mouth"-tx-4-"mouth"-noun-0]|TX|819/5|
00000000|MMI|3.43|Monitoring - action|C1283169|[hlca]|["Monitoring"-tx-23-"monitoring"-noun-0]|TX|4228/10|
00000000|MMI|3.43|Oral region|C0230028|[blor]|["Mouth"-tx-4-"mouth"-noun-0]|TX|819/5|
00000000|MMI|3.43|Preventive monitoring|C0150369|[hlca]|["Monitoring"-tx-23-"monitoring"-noun-0]|TX|4228/10|
00000000|MMI|3.43|acute|C0205178|[tmco]|["ACUTE"-tx-16-"acute"-adj-0]|TX|3315/5|
00000000|MMI|3.43|Medical problem:Finding:Point in time:^Patient:Nominal|C1715372|[clna]|["Medical problem"-tx-9-"medical problems"-noun-0]|TX|2803/16|
00000000|MMI|3.43|Patient Problem|C1254481|[fndg]|["Medical Problem"-tx-9-"medical problems"-noun-0]|TX|2803/16|
00000000|MMI|3.43|Beginning|C0439659|[tmco]|["Start"-tx-4-"Starting"-adj-0]|TX|753/8|
00000000|MMI|3.43|Evaluation procedure|C1261322|[hlca]|["Evaluation"-tx-2-"evaluation"-noun-0]|TX|317/10|
00000000|MMI|3.43|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-2-"HO"-noun-0]|TX|314/2|
00000000|MMI|3.43|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-2-"HO"-noun-0]|TX|314/2|
00000000|MMI|3.43|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-2-"PM"-adj-0]|TX|295/2|
00000000|MMI|3.43|Recommendation|C0034866|[idcn]|["recommendations"-tx-22-"recommendations"-noun-0]|TX|4159/15|
00000000|MMI|3.43|Sint Maarten (Dutch Part)|C3539997|[geoa]|["SX"-tx-17-"sx"-noun-0]|TX|3482/2|
00000000|MMI|3.43|South Georgia and the South Sandwich Islands|C1519428|[geoa]|["SX"-tx-17-"sx"-noun-0]|TX|3482/2|
00000000|MMI|3.43|Testicular Cancer Serum Markers Test Result SX|C3815196|[lbtr]|["SX"-tx-17-"sx"-noun-0]|TX|3482/2|
00000000|MMI|3.43|Total Amyloid Precursor Protein Measurement|C3887695|[lbpr]|["APPT"-tx-8-"appt"-noun-0]|TX|1723/4|
00000000|MMI|3.43|agreement|C0680240|[socb]|["according"-tx-22-"according"-prep-0]|TX|4138/9|
00000000|MMI|3.42|Weekly|C0332174|[tmco]|["/week"-tx-9-"week"-noun-0]|TX|1870/4|
00000000|MMI|3.42|week|C0439230|[tmco]|["WEEK"-tx-9-"week"-noun-0]|TX|1870/4|
00000000|MMI|3.42|+2|C0740116|[qnco]|["+2"-tx-9-"2"-integer-0]|TX|2730/1|
00000000|MMI|3.42|2+|C3833492|[fndg]|["2+"-tx-9-"2"-integer-1]|TX|2730/1|
00000000|MMI|3.42|2+ Score|C2827735|[